Shire PLC Rating Reiterated by Cenkos Securities Ltd (SHP)
Shire PLC (LON:SHP)‘s stock had its “buy” rating reaffirmed by research analysts at Cenkos Securities Ltd in a report released on Monday, StockRatingsNetwork reports. They currently have a GBX 3,703 ($62.06) target price on the stock. Cenkos Securities Ltd’s target price would indicate a potential upside of 15.04% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at Credit Suisse raised their price target on shares of Shire PLC from GBX 3,200 ($53.63) to GBX 3,400 ($56.98) in a research note on Friday. They now have a “neutral” rating on the stock. Separately, analysts at Citigroup Inc. raised their price target on shares of Shire PLC from GBX 3,200 ($53.63) to GBX 3,600 ($60.33) in a research note on Wednesday, February 12th. They now have a “buy” rating on the stock. Finally, analysts at UBS AG reiterated a “neutral” rating on shares of Shire PLC in a research note on Tuesday, February 11th. They now have a GBX 3,180 ($53.29) price target on the stock. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. Shire PLC presently has an average rating of “Buy” and a consensus target price of GBX 2,607.99 ($43.71).
Shares of Shire PLC (LON:SHP) opened at 3249.0002 on Monday. Shire PLC has a 52 week low of GBX 1853.0001 and a 52 week high of GBX 3211.00. The stock’s 50-day moving average is GBX 2984. and its 200-day moving average is GBX 2686.56.
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.